Tandem Diabetes Care
TNDM
TNDM
116 hedge funds and large institutions have $735M invested in Tandem Diabetes Care in 2018 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 24 increasing their positions, 24 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
55% more funds holding
Funds holding: 75 → 116 (+41)
18.99% more ownership
Funds ownership: 47.71% → 66.7% (+19%)
0% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 24
Holders
116
Holding in Top 10
6
Calls
$22.3M
Puts
$12.1M
Top Buyers
| 1 | +$63.7M | |
| 2 | +$49.7M | |
| 3 | +$42.9M | |
| 4 |
O
OrbiMed
New York
|
+$37.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$27.3M |
Top Sellers
| 1 | -$62.3M | |
| 2 | -$7.76M | |
| 3 | -$7.49M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$6.68M |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$4.73M |